MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$28,895K
EPS
-$0.3
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Research and development
13,314
General and administrative
15,411
Total operating expenses
28,725
Loss from operations
-28,725
Change in fair value of warrant derivative
-153
Fair value loss from standby equity purchase agreement (sepa arrangement)
-388
Foreign exchange (loss) gain
-106
Interest income
386
Total other income, net
45
Loss before income taxes
-28,680
Income tax expense
79
Net loss
-28,759
Translation adjustments
-136
Comprehensive loss
-28,895
Basic EPS
-0.3
Diluted EPS
-0.3
Basic Average Shares
95,857,147
Diluted Average Shares
95,857,147
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive loss-$28,895K Net loss-$28,759K Translation adjustments-$136K Interest income$386K Change in fair value ofwarrant derivative-$153K Loss before incometaxes-$28,680K Income tax expense$79K Total other income,net$45K Fair value loss fromstandby equity purchase...-$388K Foreign exchange (loss)gain-$106K Loss from operations-$28,725K Total operatingexpenses$28,725K General andadministrative$15,411K Research and development$13,314K

ONCOLYTICS BIOTECH INC (ONCY)

ONCOLYTICS BIOTECH INC (ONCY)